Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ABL MEDICAL CARE LLC

NPI: 1295252815 · WINTER SPRINGS, FL 32708 · Clinical Medical Laboratory · NPI assigned 08/24/2017

$1.08M
Total Medicaid Paid
43,836
Total Claims
39,379
Beneficiaries
23
Codes Billed
2019-07
First Month
2023-03
Last Month

Provider Details

Authorized OfficialTAYLOR, MICHELLE (LABORATORY DIRECTOR)
NPI Enumeration Date08/24/2017

Related Entities

Other providers sharing the same authorized official: TAYLOR, MICHELLE

ProviderCityStateTotal Paid
EAST CAROLINA HEALTH-BEAUFORT INC WASHINGTON NC $2.38M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 843 $26K
2020 12,833 $317K
2021 24,334 $597K
2022 5,688 $140K
2023 138 $470.99

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 8,050 7,488 $537K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6,922 6,007 $379K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 6,424 5,601 $76K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 7,743 7,217 $42K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 199 159 $16K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 10,421 9,475 $12K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 410 356 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 641 535 $6K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 62 53 $3K
80053 Comprehensive metabolic panel 276 199 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 16 15 $917.63
80061 Lipid panel 278 200 $284.61
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 91 75 $228.63
83036 Hemoglobin; glycosylated (A1C) 148 112 $220.16
85025 Blood count; complete (CBC), automated, and automated differential WBC count 341 246 $203.74
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 66 49 $202.02
84443 Thyroid stimulating hormone (TSH) 144 97 $152.43
82607 63 49 $48.80
82746 16 14 $8.74
36415 Collection of venous blood by venipuncture 75 55 $4.83
83540 17 12 $3.85
99072 1,378 1,338 $0.00
99001 55 27 $0.00